Skip to main content
PMC home page
Public Health Reports logoLink to Public Health Reports
. 1990 Jan-Feb;105(1):59–64.

Awareness and use of hepatitis B vaccine among homosexual male clients of a Boston community health center.

J McCusker 1, E M Hill 1, K H Mayer 1
PMCID: PMC1579981  PMID: 2137937

Abstract

Factors associated with awareness and acceptance of hepatitis B vaccine were identified among 150 homosexual male clients of a Boston community health center. Five percent of the subjects were unaware of hepatitis B and 25 percent had a history of hepatitis. Among the remaining 106 men, 68 percent were aware of the vaccine, and 25 percent of these had been vaccinated. Awareness of vaccine was associated with education beyond the baccalaureate level. Factors associated with vaccination included at least one prior visit to the health center, having health insurance, and extent of knowledge of the effects of hepatitis B. Among those not vaccinated, 68 percent would like to be but were deterred by the perceived high cost of the vaccine. The predominant reason given by the 31 percent who have decided not to be vaccinated was the perception that they were not at risk because of monogamous sexual relationships, or "safer" sexual practices. Strategies for maximizing vaccine use among homosexually active men should focus on increasing both awareness of the vaccine and appropriate perceptions of risk.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W., Belsey E. M., McCutchan J. A., Mindel A. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. Br Med J (Clin Res Ed) 1983 May 21;286(6378):1621–1624. doi: 10.1136/bmj.286.6378.1621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson A. C., Hodges G. R. Acceptance of hepatitis B vaccine among high-risk health care workers. Am J Infect Control. 1983 Dec;11(6):207–211. doi: 10.1016/0196-6553(83)90001-9. [DOI] [PubMed] [Google Scholar]
  3. Blumberg B. S., London W. T. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N Engl J Med. 1981 Mar 26;304(13):782–784. doi: 10.1056/NEJM198103263041312. [DOI] [PubMed] [Google Scholar]
  4. Bodenheimer H. C., Jr, Fulton J. P., Kramer P. D. Acceptance of hepatitis B vaccine among hospital workers. Am J Public Health. 1986 Mar;76(3):252–255. doi: 10.2105/ajph.76.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chin J. The use of hepatitis B virus vaccine. N Engl J Med. 1982 Sep 9;307(11):678–679. doi: 10.1056/NEJM198209093071110. [DOI] [PubMed] [Google Scholar]
  6. Dienstag J. L., Werner B. G., Polk B. F., Snydman D. R., Craven D. E., Platt R., Crumpacker C. S., Ouellet-Hellstrom R., Grady G. F. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med. 1984 Jul;101(1):34–40. doi: 10.7326/0003-4819-101-1-34. [DOI] [PubMed] [Google Scholar]
  7. Francis D. P., Chin J. The prevention of acquired immunodeficiency syndrome in the United States. An objective strategy for medicine, public health, business, and the community. JAMA. 1987 Mar 13;257(10):1357–1366. [PubMed] [Google Scholar]
  8. Francis D. P., Hadler S. C., Prendergast T. J., Peterson E., Ginsberg M. M., Lookabaugh C., Holmes J. R., Maynard J. E. Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med. 1984 Jan;76(1):69–74. doi: 10.1016/0002-9343(84)90752-6. [DOI] [PubMed] [Google Scholar]
  9. Francis D. P., Hadler S. C., Thompson S. E., Maynard J. E., Ostrow D. G., Altman N., Braff E. H., O'Malley P., Hawkins D., Judson F. N. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982 Sep;97(3):362–366. doi: 10.7326/0003-4819-97-3-362. [DOI] [PubMed] [Google Scholar]
  10. Francis D. P., Maynard J. E. The transmission and outcome of hepatitis A, B, and non-A, non-B: a review. Epidemiol Rev. 1979;1:17–31. doi: 10.1093/oxfordjournals.epirev.a036208. [DOI] [PubMed] [Google Scholar]
  11. Kane M. A., Hadler S. C., Maynard J. E. Antibody to hepatitis B surface antigen and screening before hepatitis B vaccination. Ann Intern Med. 1985 Nov;103(5):791–793. doi: 10.7326/0003-4819-103-5-791. [DOI] [PubMed] [Google Scholar]
  12. Mayer K. H., Ayotte D., Groopman J. E., Stoddard A. M., Sarngadharan M., Gallo R. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am J Med. 1986 Mar;80(3):357–363. doi: 10.1016/0002-9343(86)90706-0. [DOI] [PubMed] [Google Scholar]
  13. McCusker J., Stoddard A. M., Mayer K. H., Cowan D. N., Groopman J. E. Behavioral risk factors for HIV infection among homosexual men at a Boston community health center. Am J Public Health. 1988 Jan;78(1):68–71. doi: 10.2105/ajph.78.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McCusker J., Stoddard A. M., Zapka J. G., Zorn M., Mayer K. H. Predictors of AIDS-preventive behavior among homosexually active men: a longitudinal study. AIDS. 1989 Jul;3(7):443–448. doi: 10.1097/00002030-198907000-00007. [DOI] [PubMed] [Google Scholar]
  15. McKusick L., Wiley J. A., Coates T. J., Stall R., Saika G., Morin S., Charles K., Horstman W., Conant M. A. Reported changes in the sexual behavior of men at risk for AIDS, San Francisco, 1982-84--the AIDS Behavioral Research Project. Public Health Rep. 1985 Nov-Dec;100(6):622–629. [PMC free article] [PubMed] [Google Scholar]
  16. Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]
  17. Palmer D. L., King R. Attitude toward hepatitis vaccination among high-risk hospital employees. J Infect Dis. 1983 Jun;147(6):1120–1121. doi: 10.1093/infdis/147.6.1120. [DOI] [PubMed] [Google Scholar]
  18. Sacks H. S., Rose D. N., Chalmers T. C. Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis. JAMA. 1984 Dec 28;252(24):3375–3377. [PubMed] [Google Scholar]
  19. Schreeder M. T., Thompson S. E., Hadler S. C., Berquist K. R., Zaidi A., Maynard J. E., Ostrow D., Judson F. N., Braff E. H., Nylund T. Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis. 1982 Jul;146(1):7–15. doi: 10.1093/infdis/146.1.7. [DOI] [PubMed] [Google Scholar]
  20. Stevens C. E., Taylor P. E., Tong M. J., Toy P. T., Vyas G. N., Nair P. V., Weissman J. Y., Krugman S. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987 May 15;257(19):2612–2616. doi: 10.1001/jama.257.19.2612. [DOI] [PubMed] [Google Scholar]
  21. Szmuness W., Much I., Prince A. M., Hoofnagle J. H., Cherubin C. E., Harley E. J., Block G. H. On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med. 1975 Oct;83(4):489–495. doi: 10.7326/0003-4819-83-4-489. [DOI] [PubMed] [Google Scholar]
  22. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  23. Willoughby B., Schechter M. T., Mathias R. G., Boyko W. J., Jeffries E., Kettyls D. Seroepidemiology of hepatitis B infection in a male homosexual population. Can J Public Health. 1986 Sep-Oct;77(5):349–353. [PubMed] [Google Scholar]

Articles from Public Health Reports are provided here courtesy of SAGE Publications

RESOURCES